Page last updated: 2024-08-17

carbostyril and Retinal Diseases

carbostyril has been researched along with Retinal Diseases in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Jiang, N; Li, Y; Li, Z; Su, W; Wan, P; Yu, Z; Zhang, Y; Zhu, Y; Zhuo, Y1
Audo, I; Faure, C; Letessier, JB; Robert, MP; Zeitz, C1
Hirano, K; Kato, K; Kondo, M; Matsubara, H; Matsunaga, K; Sugimoto, M; Takashima, Y1

Trials

1 trial(s) available for carbostyril and Retinal Diseases

ArticleYear
Effect of topical rebamipide on conjunctival goblet cell recovery after vitrectomy.
    Scientific reports, 2016, Jan-14, Volume: 6

    Topics: Aged; Alanine; Cell Count; Conjunctiva; Female; Goblet Cells; Humans; Male; Middle Aged; Quinolones; Retinal Diseases; Time Factors; Treatment Outcome; Vitrectomy

2016

Other Studies

2 other study(ies) available for carbostyril and Retinal Diseases

ArticleYear
Laquinimod exerts anti-inflammatory and antiapoptotic effects in retinal ischemia/reperfusion injury.
    International immunopharmacology, 2020, Volume: 88

    Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Cells, Cultured; Cytokines; Inflammation; Male; Mice; Mice, Inbred C57BL; Quinolones; Reperfusion Injury; Retina; Retinal Diseases; Retinal Neurons; Retinal Vessels

2020
Aripiprazole-induced chorioretinopathy: multimodal imaging and electrophysiological features.
    Documenta ophthalmologica. Advances in ophthalmology, 2015, Volume: 131, Issue:1

    Topics: Antipsychotic Agents; Aripiprazole; Coloring Agents; Dark Adaptation; Electrooculography; Electroretinography; Female; Fluorescein Angiography; Humans; Indocyanine Green; Middle Aged; Multimodal Imaging; Piperazines; Quinolones; Retina; Retinal Diseases; Retinal Pigment Epithelium; Schizophrenia; Tomography, Optical Coherence; Visual Acuity

2015